Pharma Commercial Forecasting Expert — Launch Curves

What you would do

• Review AI launch curves and commercial programs, critiquing market share and uptake trajectory assumptions
• Build or evaluate rubrics that distinguish sound commercial forecasts from defensive AI reasoning
• Verify whether AI assumptions about competitor analogs hold up in actual pharmaceutical competitive dynamics
• Assess ramp rates, peak-share timing, and loss-of-exclusivity impact assumptions against pharma precedent
• Identify gaps between AI reasoning and actual commercial realities in drug development

Who they want

• 5+ years in pharma commercial forecasting, analytics, strategy, or sales team experience
• Hands-on experience building or critiquing drug launch and uptake models
• US-based, familiarity with biotech and pharma development program structures
• Ability to evaluate whether competitive forecast assumptions are defensible in market context
• Clear written and verbal communication for explaining forecast judgment to technical stakeholders

Main skills

What the interview asks about

1. 1.Launch curve realism assessment

   Defending uptake assumptions requires understanding both competitive and clinical factors that shape adoption.

   For example: “An AI forecasts a cardiovascular drug reaching 40% market share by year 3 against three established competitors with 15% share each. What questions would you ask about competitive differentiation and prescriber adoption to test this assumption?”

2. 2.Analog selection justification

   Choosing correct comparator drugs is foundational to credible forecasts; this tests whether you know which characteristics make drugs comparable.

   For example: “You're asked to use Drug A as a launch analog for Drug B. Drug A saw 8% peak share in a 5-drug market; Drug B will face 12 competitors. What factors would lead you to accept or reject this analog?”

3. 3.Exclusivity loss scenario building

   Patent cliffs reshape commercial trajectories fundamentally; this tests whether you account for generic entry timing and impact.

   For example: “A drug loses exclusivity in year 8 when it holds 25% market share. Build a peak-to-generic-entry trajectory, explaining assumptions about price decline and volume shift.”

4. 4.Competitive dynamics interpretation

   Real market share estimates require understanding both therapy landscape and strategic responses; this tests deeper commercial insight.

   For example: “Two pipeline competitors in the same indication are expected to launch within 18 months of your drug's launch. How would this reshape your peak-share and trajectory assumptions?”

5. 5.Rubric consistency under variation

   Assessment criteria must work across diverse drugs and programs; this tests whether your framework is robust rather than ad-hoc.

   For example: “Design three forecast evaluation criteria that would fairly distinguish strong from weak launch assumptions across oncology, cardiovascular, and infectious disease programs.”

6. 6.Defensibility threshold judgment

   Sometimes aggressive forecasts are justified by competitive positioning or clinical benefits; this tests whether you differentiate rigor from conservatism.

   For example: “An AI forecast shows 35% peak share for a first-in-class therapy with meaningful efficacy advantage over five existing therapies. On what specific factors would you determine whether this is bold but defensible or unrealistic?”

A task you may get

Review an AI-generated drug launch rubric. Identify three improvements needed, then apply it to a program, explaining your acceptance or rejection of its commercial assumptions.

How to prepare

• Review 2-3 drug launch analyses you've prepared or seen, noting which assumptions proved accurate and which missed
• Prepare a case where analog selection was critical to forecasting accuracy and where wrong analogs led to errors
• Study loss-of-exclusivity transitions in 2-3 mature drugs, documenting revenue and share impact
• Articulate your personal framework for what makes a launch assumption 'defensible' vs. speculative

The facts

Pay

$130–210/hr

Hours

Part time, 15 hours a week

Where

Remote · Remote — US based or deep US market experience

Open to

USA, USA

Field

Business Operations

Posted

8/5/2026

Places left

5

We wrote this page from the public Mercor listing. It may be out of date, so read the full posting before you apply.